That 'historic breakthrough' hyped by Trump and Hahn? The NIH isn't impressed
The NIH just threw a bucket of cold water on President Trump’s ballyhooed “historic breakthrough” with convalescent plasma as a treatment for Covid-19.
In a statement out on Tuesday, a panel of experts convened by the government’s premier agency involved in funding discovery and translational research viewed the results from clinical trials and flatly concluded that “there are currently no data from well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety of convalescent plasma for the treatment of COVID-19.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 128,800+ biopharma pros reading Endpoints daily — and it's free.